Rhythm Pharmaceuticals, Inc. (RYTM)
91.97
-0.21
(-0.23%)
USD |
NASDAQ |
Oct 28, 16:00
92.96
+0.99
(+1.08%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price to Book Value : 61.46 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 61.46 |
| October 27, 2026 | 61.60 |
| October 26, 2026 | 59.79 |
| October 23, 2026 | 59.65 |
| October 22, 2026 | 60.74 |
| October 21, 2026 | 59.22 |
| October 20, 2026 | 60.27 |
| October 19, 2026 | 58.96 |
| October 16, 2026 | 57.58 |
| October 15, 2026 | 58.78 |
| October 14, 2026 | 57.94 |
| October 13, 2026 | 57.88 |
| October 12, 2026 | 60.02 |
| October 09, 2026 | 60.66 |
| October 08, 2026 | 59.90 |
| October 07, 2026 | 59.11 |
| October 06, 2026 | 60.66 |
| October 05, 2026 | 61.78 |
| October 02, 2026 | 62.03 |
| October 01, 2026 | 62.42 |
| September 30, 2026 | 63.63 |
| September 29, 2026 | 63.96 |
| September 28, 2026 | 65.86 |
| September 25, 2026 | 65.93 |
| September 24, 2026 | 65.69 |
| Date | Value |
|---|---|
| September 23, 2026 | 65.65 |
| September 22, 2026 | 66.34 |
| September 21, 2026 | 66.04 |
| September 18, 2026 | 65.29 |
| September 17, 2026 | 66.17 |
| September 16, 2026 | 65.49 |
| September 15, 2026 | 64.67 |
| September 14, 2026 | 68.45 |
| September 11, 2026 | 69.97 |
| September 10, 2026 | 68.29 |
| September 09, 2026 | 67.53 |
| September 08, 2026 | 68.03 |
| September 04, 2026 | 68.65 |
| September 03, 2026 | 70.09 |
| September 02, 2026 | 70.45 |
| September 01, 2026 | 69.99 |
| August 31, 2026 | 70.92 |
| August 28, 2026 | 71.61 |
| August 27, 2026 | 75.20 |
| August 26, 2026 | 74.76 |
| August 25, 2026 | 75.74 |
| August 24, 2026 | 74.47 |
| August 21, 2026 | 73.51 |
| August 20, 2026 | 72.78 |
| August 19, 2026 | 77.33 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 22.95 |
| BioMarin Pharmaceutical, Inc. | 1.714 |
| Cytokinetics, Inc. | -- |
| Exelixis, Inc. | 8.947 |
| Ionis Pharmaceuticals, Inc. | 16.91 |
Price to Book Value Related Metrics
| PS Ratio | 25.85 |
| PEG Ratio | -8.911 |
| Price | 91.97 |
| Earnings Yield | -3.39% |
| Market Cap | 6.329B |
| PEGY Ratio | -8.911 |